ArticleOphthalmology science2026

Low Rates of Fibrosis in Eyes Treated with the Port Delivery Platform with Ranibizumab or with Monthly Ranibizumab in the Archway Trial.

Usha Chakravarthy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.